However, pharmacological intervention using SIRT1 and NRF2 activator resveratrol improved renal function, proteinuria, glomerulosclerosis, tubular fibrosis, and inflammation in aged kidneys [38, 42]. The gene discussed is NFE2L2; the disease is glomerulosclerosis.